Could the pill replace other sleep apnea treatments? When used properly, CPAP machines are currently the most effective option for treating sleep apnea.

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat sleep apnea. It's taken before bedtime to help keep airways open during ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, compared to those who don’t have it.

And if left untreated, sleep apnea can increase the risk for serious conditions such as high blood pressure, Type 2 diabetes, heart attack and stroke.

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results from its stage III clinical trial.

For the estimated 54 million Americans with obstructive sleep apnea, bedtime isn't refreshing. Their airways are partially blocked during sleep, leading to daytime grogginess and lasting health ...

Apnimed has scored another phase 3 knockout. | Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the number of nightly ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with obstructive sleep apnea (OSA).